Comments
Torrent Pharmaceuticals today reported 13.29 per cent decline in its consolidated net profit at Rs 163 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 188 crore during the same period of the previous fiscal.
Revenue of the company, however, increased by 37 per cent during the April-June period of the current fiscal at Rs 1,872 crore as compared with Rs 1,362 crore during the same period of last year, Torrent Pharma said in a regulatory filing.
Amortisation impact of acquiring branded business of Unichem Laboratories in December 2017 and lower foreign exchange gains impacted the company’s profit during the first quarter, it added.
On a standalone basis, the company posted a net profit of Rs 122 crore, up 45.23 per cent, from Rs 84 crore in the same period of 2017-18.
Shares of Torrent Pharma today ended 0.14 per cent down at Rs 1,522.70 apiece on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.